Martin Hillsten on the directed share issue
Integrum’s CEO Martin Hillsten sees that increased financial stability will enable the company to more quickly seize the opportunities now opening up in both the US and Ukraine.
Published
Integrum’s CEO Martin Hillsten sees that increased financial stability will enable the company to more quickly seize the opportunities now opening up in both the US and Ukraine.
Published
The company will receive approximately SEK 22.9 million before deduction of transaction costs. Investors include Cicero Fonder, Nowo Fund Management, Curam Holding, Maria Anderkvist, Förvaltnings AB Grötlingboudd,...
Published
A clinical study led by Shirley Ryan AbilityLab has reached its first milestone, with the first U.S. patient implanted with e-OPRA™ – a key step in the development of implantable intelligent bionics.
Published
"We look forward to continuing to support Ukrainian hospitals and surgeons in building capacity and expertise in this field," says Dr. Rickard Brånemark.
Published
Read Integrum’s interim report for the first quarter of the company’s financial year.
Published
On Thursday September 3rd 2026, CEO Martin Hillsten and CFO Louise Wåhlin presented the company’s results for the first quarter of 2026/27. Watch the presentation here.
Published
Comment by: Martin Hillsten
The shareholders of Integrum are hereby invited to the Annual General Meeting on 29 September 2026 at 16:00 at GoCo Health Innovation City.
Published
In an interview with Börsvärlden, our CEO Martin Hillsten talks about the company's next phase. After a year marked by transformation, cost savings and a strengthened commercial organization, the company...
Published
Dagens Industri's Medtech & Digital Hälsa reports that Ukraine's Ministry of Health has forwarded a proposal to the government to introduce osseointegration as part of national treatment for amputees.
Published
Ukraine's Ministry of Health is finalising its review of the proposal to introduce osseointegration into the national healthcare system and is referring the draft proposal to the Cabinet of Ministers.
Published
Rickard Brånemark, chief medical and scientific officer of Integrum, has written a commentary for Nordic Life Science about his experiences from the war.
Published
The subsidiary Afyri will unlock the potential within e-OPRA and create an AI based platform for the interface between human and prosthesis.
Published